The Gold Trade, May 24
Health Care: Drugs
Theravance Inc. (THRX: NASDAQ)
$36.24 -0.54 | -1.47%
05/24/13 - 04:00 PM ET
Latest Dividend:0.00
Latest Dividend Yield:0.00%
Dividend Ex-Date:12/31/69
Price Earnings Ratio:n/a
Price Earnings Comparisons:
| THRX | Sector Avg. | S&P 500 |
|---|---|---|
| n/a | 0.00 | 17.70 |
Price Performance History (% change):
| 3 Mo | 1 Yr | 3 Yr |
|---|---|---|
| 69.96 | 71.84 | 179.91 |
| GROWTH | 12 Mo | 3 Yr | CAGR |
|---|---|---|---|
| Revenue | 453.80 | 4.57 | 0.76 |
| Net Income | 0.00 | 0.00 | |
| EPS | -0.85 | 0.00 |
Earnings for THRX:
| EBITDA | -12.00 |
| REVENUE | 135.76M |
Average Earnings Estimates
| Qtr (06/13) | Qtr (09/13) | FY (12/13) | FY (12/14) | |
|---|---|---|---|---|
| Average Estimate | $-0.59 | $-0.58 | $-1.79 | $-1.00 |
| Number of Analysts | 3 | 2 | 3 | 5 |
| High Estimate | $-0.34 | $-0.34 | $-1.31 | $-0.44 |
| Low Estimate | $-0.74 | $-0.83 | $-2.25 | $-1.77 |
| Prior Year | $-0.42 | $-0.37 | $-0.20 | $-1.79 |
| Growth Rate (Year over Year) | -41.27% | -58.11% | -795.00% | 44.36% |
Portfolios with THRX
- Portfolio NameUser Type
- ContributorStocks Rising On Unusual Vo...
- ContributorStocks With Big Insider Buy...
- ContributorEarnings Short Squeeze Play...
- ProSeth Klarman - Baupost Group
- ContributorStocks With Big Insider Buy...
- ContributorStocks With Big Insider Buy...
- ContributorEarnings Short Squeeze Play...
- ContributorStocks Rising On Unusual Vo...
- ContributorStocks Rising On Unusual Vo...
- Usernew
Latest THRX Headlines from TheStreet
- Stocks Finish Flat as Earnings Wind Down 05.13.13 | 11:05 am
- Stock Futures Lower Ahead of Retail Sales 05.13.13 | 06:05 am
- 4 Stocks Spiking on Big Volume 05.10.13 | 03:05 pm
- Buffett's Long-Term, High-Dividend Plays 05.04.13 | 03:05 am
- Theravance Inc. (THRX): Today's Featured Health Care Laggard 04.19.13 | 05:04 pm
- 3 Stocks Pushing The Drugs Industry Higher 04.15.13 | 01:04 pm
- 5 Stocks Poised to Pop on Bullish Earnings 02.11.13 | 12:02 pm
- Insiders Trading THRX KSS TUES ELGX 11.06.12 | 10:11 am
- Theravance And Merck Sign Cardiovascular Disease Collaboration 10.16.12 | 08:10 am
- Theravance And Alfa Wassermann Enter Into Agreement To Develop And Commercialize Velusetrag For Gastroparesis 10.02.12 | 04:10 pm
Press Releases for THRX
- BREOâ¿¢ ELLIPTAâ¿¢ Gains US Approval For The Treatment Of COPD - PR Newswire 05.10.13 | 04:05 pm
- FDA Advisory Committee Recommends Approval Of BREOâ¿¢ ELLIPTAâ¿¢ For The Treatment Of COPD - PR Newswire 04.17.13 | 05:04 pm
Partner Headlines for THRX
- Elan steps up fight against Royalty Pharma bid - Financial Times 05.20.13 | 05:05 pm
- Theravance, Glaxo, Elan Star In Biotech Soap Opera - Investor's Business Daily 05.13.13 | 05:05 pm
- Glaxo, Theravance Confirm BREO ELLIPTA Gained US FDA Approval for Treatment of COPD - Benzinga 05.10.13 | 12:05 pm
- Theravance Earnings: Here’s Why Investors Don’t Like These Results - Wall St. Cheat Sheet 04.25.13 | 08:04 am
- Morning Market Movers - Benzinga 04.15.13 | 09:04 am
- Pipeline Progress at Theravance - Analyst Blog - Zacks 12.05.12 | 09:12 am
- Glaxo Invests in Nigeria - Analyst Blog - Zacks 11.28.12 | 09:11 am
- For NovaBay, Simplicity Is The Father Of Invention - Seeking Alpha 11.12.12 | 09:11 am
- Loss at THRX Narrower Than Expected - Analyst Blog - Zacks 10.31.12 | 09:10 am
- Glaxo Aims to Expand Synflorix Label - Analyst Blog - NASDAQ 09.19.12 | 03:09 pm
